Securities Code: 300841 Securities Abbreviation: Kanghua Bio Announcement No.: 2026-016
Chengdu Kanghua Bio-products Co., Ltd. Special Report on the Status of Raised Funds' Deposit and Use for 2025
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and are free from any false representations, misleading statements, or material omissions.
In accordance with the "Supervision Rules for the Management of Raised Funds by Listed Companies" (CSRC Announcement [2025] No. 10), the "Shenzhen Stock Exchange Listed Company Self-Regulatory Management Guidelines No. 2 - Norms for the Operation of GEM Listed Companies," and the "Shenzhen Stock Exchange GEM Listed Company Self-Regulatory Management Guide No. 2 - Announcement Format" and other relevant regulations, Chengdu Kanghua Bio-products Co., Ltd. (hereinafter referred to as the "Company") hereby presents this special report on the deposit, management, and use of raised funds for 2025:
I. Basic情况 of Raised Funds
(I) Amount of Funds Actually Raised and Time of Arrival
Approved by the "Approval for the Initial Public Offering of Ordinary Shares (A Shares) of Chengdu Kanghua Bio-products Co., Ltd." (Securities Regulatory Permit [2020] No. 521) issued by the China Securities Regulatory Commission, the Company issued 15.00 million ordinary shares (A shares) at an issue price of RMB 70.37 per share, totaling 15.00 million new shares. The total amount of funds raised was RMB 105,555.00 million. After deducting issuance expenses of RMB 7,457.70 million, the net amount of raised funds was RMB 98,097.30 million. The arrival of the raised funds was audited by Lixin Certified Public Accountants (Special General Partnership) in their "Capital Verification Report" No. ZD10135 [2020] dated June 10, 2020. The Company adopts a special deposit system for raised funds.
(II) Status of Raised Funds Use and Balance
As of December 31, 2025, the Company's raised funds usage and balance are as follows (amount in RMB):
| Item | Amount (RMB) |
|---|---|
| Net amount of raised funds as of Dec 31, 2019 | |
| Add: Net amount of raised funds received in 2020 | 980,973,000.00 |
| Less: Raised funds used in 2020 | |
| Less: Raised funds used in 2021 | 258,674,305.67 |
| Less: Raised funds used in 2022 | 218,755,218.13 |
| Less: Raised funds used in 2023 | 261,845,493.69 |
| Less: Raised funds used in 2024 | 35,458,694.47 |
| Less: Raised funds used in 2025 | 42,804,314.60 |
| Less: Balance of raised funds for working capital | 22,398,325.00 |
| Add: Net interest income less handling fees | 1.73 |
| Balance of raised funds as of Dec 31, 2025 | 46,055,551.72 |
| Of which: Balance of unused funds in special accounts | 187,092,198.43 |
| Balance of funds for cash management of idle funds not yet due | 187,092,198.43 |
II. Status of Raised Funds Deposit and Management
(I) Management of Raised Funds
To standardize the management of the Company's raised funds and protect the interests of investors, in accordance with the "Supervision Rules for the Management of Raised Funds by Listed Companies" (CSRC Announcement [2025] No. 10), the "Shenzhen Stock Exchange Listed Company Self-Regulatory Management Guidelines No. 2 - Norms for the Operation of GEM Listed Companies," and other relevant regulations, the Company has formulated the "Raised Funds Management System." Raised funds are managed through special deposit accounts, and the use of raised funds is subject to strict approval procedures to ensure that funds are used for their intended purposes.